Osteoporosis International

, Volume 28, Issue 1, pp 407–411 | Cite as

Telementoring: a novel approach to reducing the osteoporosis treatment gap

  • E. M. Lewiecki
  • J. F. Boyle
  • S. Arora
  • M. F. BouchonvilleII
  • D. H. Chafey
Short Communication



Bone Health ECHO telementors healthcare professionals to develop the clinical skills needed to provide advanced levels of care for patients with skeletal disorders. The goal of this mentorship model is to improve osteoporosis care in underserved areas, decrease the need for referral to specialty centers, and reduce the osteoporosis treatment gap.


The Project ECHO (Extension for Community Healthcare Outcomes) model of telementoring has been shown to improve the care individuals with chronic hepatitis C. ECHO has since been adapted to the address unmet needs in the care of other chronic complex diseases and recently applied to the care of osteoporosis and metabolic bone diseases.


Bone Health ECHO outcomes are assessed through an electronic data collector asking qualitative questions about self-efficacy. This is a progress report of Bone Health ECHO from its launch in October 2015 through May 2016.


A total of 31 weekly Bone Health ECHO clinics were held over 8 months, with 43 individuals participating at least one clinic session. The number of clinics attended range from 1 to 30, with 13 learners attending more than 10 clinics and an average of 11 learners per clinic. Self-efficacy information provided by learners was diverse with many favorable anticipated changes in clinical practice.


Bone Health ECHO telementors healthcare professionals in underserved areas to provide advanced levels of care for patients with skeletal disorders. The experience of Bone Health ECHO will guide the development of similar telementoring clinics in other locations. More data are needed to fully evaluate this novel approach to reducing the osteoporosis treatment gap.


ECHO Osteoporosis Telehealth Telemedicine Telementoring Treatment gap 


Compliance with ethical standards

Conflict of interest

E. Michael Lewiecki has received institutional grant/research support from Amgen, Merck, and Eli Lilly; he has served on scientific advisory boards for Amgen, Merck, Eli Lilly, Radius Health, Alexion, and Shire. Jeannie F. Boyle, Sanjeev Arora, Matthew F. Bouchonville II, and David H. Chafey declare that they have no conflict of interest. No writing assistance or funding was utilized in the production of this manuscript.


  1. 1.
    Drake MT, Clarke BL, Lewiecki E (2015) The pathophysiology and treatment of osteoporosis. Clin Ther 37:1837–1850CrossRefPubMedGoogle Scholar
  2. 2.
    Kanis JA, Borgstrom F, Compston J, Dreinhofer K, Nolte E, Jonsson L, Lems WF, McCloskey EV, Rizzoli R, Stenmark J (2013) SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos 8:144CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29:1929–1937CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Leslie WD, Giangregorio LM, Yogendran M, Azimaee M, Morin S, Metge C, Caetano P, Lix LM (2012) A population-based analysis of the post-fracture care gap 1996-2008: the situation is not improving. Osteoporos Int 23:1623–1629CrossRefPubMedGoogle Scholar
  5. 5.
    Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023–1031CrossRefPubMedGoogle Scholar
  6. 6.
    Yates CJ, Chauchard MA, Liew D, Bucknill A, Wark JD (2015) Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service. J Clin Densitom 18:150–156CrossRefPubMedGoogle Scholar
  7. 7.
    Arora S, Kalishman S, Dion D, et al. (2011) Partnering urban academic medical centers and rural primary care clinicians to provide complex chronic disease care. Health Aff (Millwood) 30:1176–1184CrossRefGoogle Scholar
  8. 8.
    Arora S, Thornton K, Murata G, et al. (2011) Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 364:2199–2207CrossRefPubMedGoogle Scholar
  9. 9.
    Dubin RE, Flannery J, Taenzer P, et al. (2015) ECHO Ontario Chronic Pain & Opioid Stewardship: providing access and building capacity for primary care providers in underserviced, rural, and remote communities. Stud Health Technol Inf 209:15–22Google Scholar
  10. 10.
    Kauth MR, Shipherd JC, Lindsay JA, Kirsh S, Knapp H, Matza L (2015) Teleconsultation and training of VHA providers on transgender care: implementation of a multisite hub system. Telemed J E HealthGoogle Scholar
  11. 11.
    Katzman JG, Comerci G Jr, Boyle JF, et al. (2014) Innovative telementoring for pain management: project ECHO pain. J Contin Educ Heal Prof 34:68–75CrossRefGoogle Scholar
  12. 12.
    Mitruka K, Thornton K, Cusick S, et al. (2014) Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model—Arizona and Utah, 2012-2014. MMWR Morb Mortal Wkly Rep 63:393–398PubMedGoogle Scholar
  13. 13.
    Scott JD, Unruh KT, Catlin MC, et al. (2012) Project ECHO: a model for complex, chronic care in the Pacific Northwest region of the United States. J Telemed Telecare 18:481–484CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lewiecki EM, Bouchonville MF 2nd, Chafey DH, Bankhurst A, Arora S (2016) Bone Health ECHO: telementoring to improve osteoporosis care. Women’s Health (Lond Engl) 12:79–81CrossRefGoogle Scholar
  15. 15.
    Lewiecki EM, Baron R, Bilezikian JP, Gagel RE, Leonard MB, Leslie WD, McClung MR, Miller PD (2016) Proceedings of the 2015 Santa Fe bone symposium: clinical applications of scientific advances in osteoporosis and metabolic bone disease. J Clin Densitom 19:102–116CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2016

Authors and Affiliations

  • E. M. Lewiecki
    • 1
  • J. F. Boyle
    • 2
  • S. Arora
    • 3
  • M. F. BouchonvilleII
    • 3
  • D. H. Chafey
    • 4
  1. 1.New Mexico Clinical Research & Osteoporosis CenterAlbuquerqueUSA
  2. 2.The ECHO InstituteUniversity of New Mexico/Health Sciences CenterAlbuquerqueUSA
  3. 3.Department of Internal MedicineUniversity of New Mexico School of MedicineAlbuquerqueUSA
  4. 4.Department of Orthopedics & RehabilitationUniversity of New Mexico School of MedicineAlbuquerqueUSA

Personalised recommendations